Clinical Trials Directory

Trials / Sponsors / LIB Therapeutics LLC

LIB Therapeutics LLC

Industry · 12 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingRandomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcib
Familial Hypercholesterolemia - Heterozygous
Phase 32025-09-01
CompletedTrial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
Hypercholesterolemia, Atherosclerotic Ischemic Disease
Phase 32022-06-20
CompletedCross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug P
Hypercholesterolemia
Phase 32022-01-28
CompletedTrial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
Hypercholesterolemia, Cardiovascular Diseases
Phase 32021-04-22
CompletedStudy to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C
Heterozygous Familial Hypercholesterolemia
Phase 32021-04-22
UnknownStudy of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction
Cardiovascular Diseases, Hyper-LDL-cholesterolemia
Phase 32021-04-22
UnknownStudy of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Re
Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke
Phase 32021-04-22
Enrolling By InvitationLong-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C
Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol, Familial Hypercholesterolemia
Phase 32020-12-03
CompletedPhase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH
Homozygous Familial Hypercholesterolemia
Phase 32019-12-07
CompletedOpen-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003
Hypercholesterolemia
Phase 22019-02-14
CompletedStudy to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C
LDL Cholesterol
Phase 22018-05-22
CompletedStudy to Evaluate the Safety, PK, and Pharmacodynamics of LIB003
Hypercholesterolemia
Phase 12017-10-30